Topic prioritisation
Showing 21 to 25 of 25
| Title | Prioritisation programme | Decision | Decision date |
|---|---|---|---|
| Dupilumab for children with severe atopic dermatitis [TSID10434] | None selected | Not selected | |
| Dupilumab for maintenance treatment of uncontrolled moderate to severe asthma in children 6 to 11 years [TSID10085] | None selected | Not selected | |
| Baloxavir marboxil for treating and preventing influenza in children 1 to 11 years [ID6554] | None selected | Further information required | |
| Moor LDLS-BI for assessing burn depth and healing potential in children and adults | None selected | Not selected | |
| Fingolimod for treating relapsing multiple sclerosis in children and young people [ID1378] | None selected | Not selected |